Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

POWER: Prospective, Observational Study of Wellinks Effect on COPD Hospital Readmissions

NCT05330507 is registered in ClinicalTrials.gov with Convexity Scientific Inc as lead sponsor.

NCT NCT05330507
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05330507 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
POWER: Prospective, Observational Study of Wellinks Effect on COPD Hospital Readmissions
Lead sponsor
Convexity Scientific Inc
Phase
Observational
Overall status
Unknown status
Start date
July 5, 2022
Completion date
June 30, 2024
Enrollment
150 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

copd, lung diseases, lung diseases, obstructive, pulmonary disease, chronic obstructive, respiratory tract disease